Effect of flunixin meglumine on prostaglandin F2 alpha synthesis and metabolism in the pig.
The effect of flunixin meglumine on prostaglandin synthesis and metabolism was evaluated in the pig in vivo. It was found that the prostaglandin metabolite, 15-ketodihydro-PGF2 alpha, was decreased in the peripheral circulation within 20 min of injection of the drug. In therapeutic doses in the pig the drug had no effect on the metabolism of PGF2 alpha. Flunixin was compared with some other non-steroidal anti-inflammatory drugs in an in vitro test system utilizing sheep vesicular gland microsomes. It was concluded that this drug is a potent inhibitor of prostaglandin synthesis.
Odensvik
K
K
Department of Obstetrics and Gynaecology, Faculty of Veterinary Medicine, Swedish University of Agricultural Sciences, Uppsala.
Cort
N
N
Basu
S
S
Kindahl
H
H
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D003002:Clonixin / Q000031:analogs & derivatives / Q000494:pharmacology*; D016861:Cyclooxygenase Inhibitors; D015237:Dinoprost / Q000031:analogs & derivatives / Q000096:biosynthesis* / Q000097:blood / Q000378:metabolism; D004971:Estrus / Q000378:metabolism*; D005260:Female; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology*; D013552:Swine / Q000378:metabolism*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D009539:Nicotinic Acids; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D008528:Mefenamic Acid; C014558:flunixin meglumine; D015237:Dinoprost; D001241:Aspirin; D003002:Clonixin; D007213:Indomethacin